AbCellera Biologics (ABCL)
(Delayed Data from NSDQ)
$3.01 USD
+0.04 (1.35%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $3.01 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/06/2024
Time: AMC |
6/2024 | $-0.16 | 0.00% |
Earnings Summary
For their last quarter, AbCellera Biologics (ABCL) reported earnings of -$0.14 per share, beating the Zacks Consensus Estimate of $-0.16 per share. This reflects a positive earnings surprise of 12.50%. Look out for ABCL's next earnings release on August 06, 2024. For the next earning release, we expect the company to report earnings of -$0.16 per share, reflecting a year-over-year decrease of 45.45%.
Earnings History
Price & Consensus
Zacks News for ABCL
AbCellera Biologics Inc. (ABCL) Reports Q1 Loss, Misses Revenue Estimates
ABCL: What are Zacks experts saying now?
Zacks Private Portfolio Services